Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors.

Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors.

Item
http://www.wikidata.org/entity/Q45150043
NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantationNatural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation.Immunotherapy for pediatric cancer.Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype.Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.Biologic markers of chronic GVHD.Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors.Quantification of nucleated red blood cells in allogeneic marrow graft and impact of processing on recovery.Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants
P2860

Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors.

Item
http://www.wikidata.org/entity/Q45150043
description
2005 nî lūn-bûn
@nan
2005 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Transplantation with higher do ...... om HLA-matched sibling donors.
@en
Transplantation with higher do ...... om HLA-matched sibling donors.
@nl
type
label
Transplantation with higher do ...... om HLA-matched sibling donors.
@en
Transplantation with higher do ...... om HLA-matched sibling donors.
@nl
prefLabel
Transplantation with higher do ...... om HLA-matched sibling donors.
@en
Transplantation with higher do ...... om HLA-matched sibling donors.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Transplantation with higher do ...... om HLA-matched sibling donors.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1600-0609.2005.00514.X
P433
P478
P577
P698
P921